Immuno-Oncology Drug Discovery: A CD39 Activity Assay for a Promising Target
Thursday, 02 May 2019
What comes to mind when you think of immunotherapy? The immune system, with all its complexities, contributes to numerous diseases that affect our society. It’s no wonder scientists scramble to find therapies that will either suppress (suppression immunotherapies) or activate (activation immunotherapies) an immune response. Immunotherapy isn’t only used for autoimmune diseases or infectious disease.
- Published in Emerging Targets, HTS Assays
No Comments